During the past decade, Oklahoma Heart Institute at Hillcrest Medical Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oklahoma Heart Institute at Hillcrest Medical Center" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Oklahoma Heart Institute at Hillcrest Medical Center" are "Atrial Fibrillation" (1 trials), "Coronary Artery Disease" (1 trials), "Tricuspid Regurgitation" (1 trials), "Tricuspid Valve Disease" (1 trials) and "Tricuspid Valve Insufficiency" (1 trials). Many other conditions were trialed in "Oklahoma Heart Institute at Hillcrest Medical Center" in a lesser frequency.

Most popular intervention types in "Oklahoma Heart Institute at Hillcrest Medical Center" are "Drug" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Apixaban" (1 trials), "Edwards PASCAL System" (1 trials), "Optimal Medical Therapy" (1 trials) and "Parenteral heparin and/or oral Vitamin K antagonist" (1 trials). Other intervention names were less common.

The vast majority of trials in "Oklahoma Heart Institute at Hillcrest Medical Center" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Oklahoma Heart Institute at Hillcrest Medical Center". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Oklahoma Heart Institute at Hillcrest Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Oklahoma Heart Institute at Hillcrest Medical Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".